Next Article in Journal
Impact of Combined Neuromuscular Electrical Stimulation (Comb-NMES) on Glucose Signaling and Muscle Myofiber Distribution in a Patient with Acute Spinal Cord Injury and Lower Motor Neuron Lesion
Previous Article in Journal
Autoimmune Thrombocytopenia in Pregnancy: Insights from an Uncommon Case Presentation and Mini-Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 14
Issue 3
10.3390/jcm14030874
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis

by
Kei Moriya
1,*,
Shinsaku Nagamatsu
1,
Yuya Nishio
1,
Yusuke Komeda
1,
Shoma Kikukawa
1,
Kyohei Matsuura
1,
Hideki Matsuo
1,
Masakazu Uejima
2,
Takamichi Kitagawa
3 and
Fumihiko Nakamura
3
1
Department of Gastroenterology, Nara Prefecture General Medical Center, Nara 630-8581, Japan
2
Department of Endocrinology and Metabolism, Nara Prefecture General Medical Center, Nara 630-8581, Japan
3
Department of Laboratory Medicine, Nara Prefecture General Medical Center, Nara 630-8581, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(3), 874; https://doi.org/10.3390/jcm14030874
Submission received: 11 December 2024 / Revised: 18 January 2025 / Accepted: 21 January 2025 / Published: 28 January 2025
(This article belongs to the Topic Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice)
Browse Figures
Versions Notes

Abstract

Background/Aims: Numerous patients with ulcerative colitis (UC) become mentally unstable after experiencing a long-standing, physically painful life, and their long-term prognosis is poorer than that of those who are mentally stable. The current study aimed to evaluate serum biomarkers for predicting mental instability, which is challenging to objectively quantify. Methods: In total, 29 refractory UC patients newly treated with filgotinib underwent measurements of blood parameters associated with depression and a quantitative assessment of quality of life using the Inflammatory Bowel Disease Questionnaire (IBDQ) before and after treatment initiation with a 12-week interval. The data collected were examined in relation to each other. Results: The induction of remission treatment with filgotinib resulted in a clinical response rate of 89.7% and a clinical remission rate of 86.2%, with all eight extraintestinal manifestations resolved. No adverse events were observed. The serum zinc, high-density lipoprotein cholesterol, mature brain-derived neurotrophic factor (BDNF) concentrations, and the IBDQ psychiatric subscores increased significantly after treatment (p < 0.05). Among these parameters, the mature-BDNF concentration and the IBDQ psychiatric subscore had the strongest positive correlation (R = 0.29, p = 0.08). Based on the logistic regression analysis, the mature-BDNF concentration (cutoff value: 20.5 ng/mL) had a sensitivity of 68.2%, specificity of 64.7%, and area under the curve of 0.67 for predicting psychiatric remission (subscore > 42.5) (p = 0.04). Conclusions: While it is not easy to objectively predict the degree of psychiatric instability in patients with refractory UC, serum mature-BDNF levels can be a useful biomarker.
Keywords: brain-derived neurotrophic factor (BDNF); depression; filgotinib; Inflammatory Bowel Disease Questionnaire (IBDQ); ulcerative colitis (UC) brain-derived neurotrophic factor (BDNF); depression; filgotinib; Inflammatory Bowel Disease Questionnaire (IBDQ); ulcerative colitis (UC)

Share and Cite

MDPI and ACS Style

Moriya, K.; Nagamatsu, S.; Nishio, Y.; Komeda, Y.; Kikukawa, S.; Matsuura, K.; Matsuo, H.; Uejima, M.; Kitagawa, T.; Nakamura, F. Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis. J. Clin. Med. 2025, 14, 874. https://doi.org/10.3390/jcm14030874

AMA Style

Moriya K, Nagamatsu S, Nishio Y, Komeda Y, Kikukawa S, Matsuura K, Matsuo H, Uejima M, Kitagawa T, Nakamura F. Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis. Journal of Clinical Medicine. 2025; 14(3):874. https://doi.org/10.3390/jcm14030874

Chicago/Turabian Style

Moriya, Kei, Shinsaku Nagamatsu, Yuya Nishio, Yusuke Komeda, Shoma Kikukawa, Kyohei Matsuura, Hideki Matsuo, Masakazu Uejima, Takamichi Kitagawa, and Fumihiko Nakamura. 2025. "Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis" Journal of Clinical Medicine 14, no. 3: 874. https://doi.org/10.3390/jcm14030874

APA Style

Moriya, K., Nagamatsu, S., Nishio, Y., Komeda, Y., Kikukawa, S., Matsuura, K., Matsuo, H., Uejima, M., Kitagawa, T., & Nakamura, F. (2025). Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis. Journal of Clinical Medicine, 14(3), 874. https://doi.org/10.3390/jcm14030874

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop